First Time Loading...

Surgery Partners Inc
NASDAQ:SGRY

Watchlist Manager
Surgery Partners Inc Logo
Surgery Partners Inc
NASDAQ:SGRY
Watchlist
Price: 27.07 USD 0.41% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

260m
-12%
Operating Cash Flow
Growth Rates:
1 Year
+69%
3 Years
-3%
5 Years
+93%
7 Years
+93%
10 Years
-
-238m
-5%
Investing Cash Flow
Growth Rates:
1 Year
+28%
3 Years
-151%
5 Years
-115%
7 Years
-38%
10 Years
-
-82.3m
+47%
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-99%
10 Years
-

Cash Flow Statement
Surgery Partners Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
(27)
(19)
(13)
0
73
73
82
83
85
89
79
66
29
19
12
12
(96)
(97)
(93)
(85)
45
33
21
(24)
1
21
33
76
71
103
109
107
87
45
88
112
135
158
Depreciation & Amortization
15
21
26
32
35
36
37
38
40
41
43
44
52
57
62
68
67
71
73
74
77
80
84
90
95
99
101
102
99
101
103
108
115
121
118
117
118
118
Change in Deffered Taxes
14
14
14
11
(150)
(150)
(150)
(155)
7
7
5
(14)
52
52
54
81
25
25
24
20
9
(8)
(10)
(11)
(22)
(7)
(9)
(9)
9
10
17
24
22
19
6
(1)
(2)
3
Stock-Based Compensation
1
1
2
2
8
7
7
8
2
3
3
0
0
6
7
8
9
7
7
9
10
12
12
13
13
15
16
17
17
16
16
17
18
19
19
19
18
0
Other Non-Cash Items
40
43
45
51
171
177
179
191
37
33
36
32
9
8
11
22
114
119
122
110
68
74
75
108
97
94
74
50
58
60
84
85
96
108
98
99
106
94
Cash Taxes Paid
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
2
0
0
0
2
0
0
0
2
0
0
0
2
0
0
0
2
0
0
0
1
0
Cash Interest Paid
50
0
0
0
97
0
0
0
79
0
0
0
110
0
0
0
145
0
0
0
180
0
0
0
204
0
0
0
194
0
0
0
219
0
0
0
170
0
Change in Working Capital
(20)
(32)
(34)
(40)
(44)
(35)
(21)
(39)
(43)
(36)
(55)
(29)
(21)
(20)
(5)
(29)
33
18
(3)
30
(69)
(40)
124
101
76
61
(110)
(142)
(149)
(156)
(157)
(151)
(161)
(141)
(146)
(87)
(64)
(113)
Cash from Operating Activities
22
N/A
27
+24%
38
+40%
53
+39%
85
+59%
100
+19%
128
+27%
117
-8%
125
+7%
135
+8%
108
-20%
99
-8%
121
+22%
116
-4%
134
+15%
154
+15%
145
-6%
135
-7%
122
-9%
150
+22%
130
-13%
138
+7%
293
+112%
263
-10%
247
-6%
268
+9%
88
-67%
76
-14%
87
+14%
117
+34%
157
+34%
171
+9%
159
-7%
154
-3%
164
+7%
238
+46%
294
+23%
260
-12%
Investing Cash Flow
Capital Expenditures
(9)
(14)
(19)
(24)
(33)
(40)
(42)
(44)
(39)
(34)
(34)
(31)
(30)
(33)
(30)
(36)
(40)
(42)
(56)
(63)
(74)
(74)
(62)
(51)
(43)
(46)
(51)
(59)
(58)
(61)
(70)
(72)
(81)
(87)
(90)
(92)
(89)
(86)
Other Items
(262)
(261)
(263)
(282)
(101)
(109)
(213)
(206)
(146)
(139)
(47)
(747)
(754)
(780)
(779)
(67)
(89)
(69)
(61)
(61)
(12)
(1)
(3)
35
(46)
(49)
(56)
(178)
(274)
(303)
(402)
(354)
(227)
(245)
(178)
(148)
(137)
(153)
Cash from Investing Activities
(271)
N/A
(275)
-2%
(281)
-2%
(306)
-9%
(135)
+56%
(149)
-10%
(256)
-72%
(250)
+2%
(185)
+26%
(172)
+7%
(81)
+53%
(778)
-866%
(783)
-1%
(813)
-4%
(809)
+1%
(102)
+87%
(129)
-26%
(111)
+14%
(117)
-6%
(124)
-6%
(85)
+31%
(75)
+13%
(65)
+13%
(17)
+74%
(88)
-433%
(95)
-7%
(107)
-12%
(237)
-122%
(332)
-40%
(365)
-10%
(472)
-30%
(426)
+10%
(308)
+28%
(332)
-8%
(268)
+19%
(240)
+11%
(226)
+6%
(238)
-5%
Financing Cash Flow
Net Issuance of Common Stock
(3)
0
(3)
(3)
251
0
0
0
0
0
0
310
308
306
306
(4)
(2)
0
0
0
0
0
0
0
0
261
261
261
582
321
321
321
883
0
0
0
0
0
Net Issuance of Debt
467
373
371
406
(139)
(35)
(36)
(40)
172
50
82
688
624
628
591
(50)
119
126
162
162
(2)
114
88
223
213
92
79
(53)
(44)
(33)
(36)
(39)
(656)
(650)
(640)
(613)
20
92
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(5)
(9)
(9)
(8)
(4)
0
0
0
0
0
0
0
(5)
(5)
(5)
(5)
0
0
0
0
0
0
0
0
0
Other
(153)
(69)
(82)
(97)
(78)
(89)
(84)
(80)
(101)
(92)
(104)
(175)
(163)
(175)
(174)
(108)
(116)
(116)
(146)
(156)
(134)
(126)
(107)
(131)
(146)
(173)
(178)
(162)
(217)
(203)
(206)
(203)
(185)
(188)
(188)
(188)
(175)
(174)
Cash from Financing Activities
311
N/A
301
-3%
285
-5%
306
+7%
33
-89%
127
+280%
132
+4%
131
0%
71
-46%
(41)
N/A
(22)
+48%
824
N/A
768
-7%
754
-2%
714
-5%
(172)
N/A
(6)
+96%
6
N/A
16
+195%
7
-59%
(136)
N/A
(12)
+91%
(20)
-70%
92
N/A
67
-27%
174
+161%
157
-10%
41
-74%
316
+677%
85
-73%
79
-7%
79
+0%
42
-47%
45
+6%
55
+23%
83
+50%
(155)
N/A
(82)
+47%
Change in Cash
Net Change in Cash
62
N/A
53
-15%
42
-20%
53
+25%
(17)
N/A
79
N/A
4
-95%
(2)
N/A
12
N/A
(79)
N/A
6
N/A
145
+2 480%
105
-27%
57
-46%
39
-32%
(121)
N/A
9
N/A
30
+215%
21
-28%
32
+50%
(92)
N/A
52
N/A
209
+301%
339
+62%
225
-34%
347
+54%
138
-60%
(120)
N/A
72
N/A
(163)
N/A
(237)
-46%
(176)
+26%
(107)
+39%
(133)
-25%
(50)
+63%
81
N/A
(87)
N/A
(60)
+31%
Free Cash Flow
Free Cash Flow
13
N/A
13
+6%
19
+46%
29
+50%
51
+77%
61
+18%
85
+41%
73
-14%
86
+17%
101
+18%
74
-27%
68
-9%
91
+35%
83
-9%
104
+25%
118
+14%
105
-11%
93
-11%
67
-29%
86
+30%
56
-35%
65
+16%
232
+259%
212
-8%
204
-4%
222
+9%
37
-83%
18
-53%
30
+67%
55
+88%
86
+56%
99
+15%
78
-21%
67
-15%
73
+10%
147
+100%
205
+40%
175
-15%

See Also

Summary
SGRY intrinsic value, competitors valuation, and company profile.
DCF Valuation
SGRY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SGRY stock valuation using valuation multiples.
Wall Street Estimates
SGRY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SGRY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.